Xueqin Yan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xueqin Yan has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Baihai Su
Department of Nephrology, Kidney Research Institute, West China Hospital of Sichuan University, Chengdu, China
1 shared publication - Furong Qu
Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China
1 shared publication - Haoming Tian
Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China
1 shared publication - Heyue Du
Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu 610041, China
1 shared publication - Hongmei Huang
Department of Endocrinology and Metabolism, The First People’s Hospital of Shuangliu District, China
1 shared publication - Li Liu
Department of Endocrinology and Metabolism, Second People’s Hospital of Ya’an City, China
1 shared publication
Latest Publications
- Open Access
- 11 November 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (22) , 6692
Glycated Haemoglobin A1c Variability Score Elicits Kidney Function Decline in Chinese People Living with Type 2 Diabetes
Our aim was to investigate the association of glycated haemoglobin A1c (HbA1c) variability score (HVS) with estimated glomerular filtration rate (eGFR) slope in Chinese adults living with type 2 diabetes. This cohort study included adults with type 2 diabetes attending outpatient clinics between 2011 and 2019 from a large electronic medical record-based database of diabetes in China (WECODe). We estimated the individual-level visit-to-visit HbA1c variability using HVS, a proportion of changes in HbA1c of ≥0.5% (5.5 mmol/mol). We estimated the odds of people experiencing a rapid eGFR annual decline using a logistic regression and differences across HVS categories in the mean eGFR slope using a mixed-effect model. The analysis involved 2397 individuals and a median follow-up of 4.7 years. Compared with people with HVS ≤ 20%, those with HVS of 60% to 80% had 11% higher odds of experiencing rapid eGFR annual decline, with an extra eGFR decline of 0.93 mL/min/1.73 m2 per year on average; those with HVS > 80% showed 26% higher odds of experiencing a rapid eGFR annual decline, with an extra decline of 1.83 mL/min/1.73 m2 per year on average. Chinese adults with type 2 diabetes and HVS > 60% could experience a more rapid eGFR decline.
- 11 November 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (22) , 6692
Open AccessGlycated Haemoglobin A1c Variability Score Elicits Kidney Function Decline in Chinese People Living with Type 2 Diabetes
Our aim was to investigate the association of glycated haemoglobin A1c (HbA1c) variability score (HVS) with estimated glomerular filtration rate (eGFR) slope in Chinese adults living with type 2 diabetes. This cohort study included adults with type 2 diabetes attending outpatient clinics between 2011 and 2019 from a large electronic medical record-based database of diabetes in China (WECODe). We estimated the individual-level visit-to-visit HbA1c variability using HVS, a proportion of changes in HbA1c of ≥0.5% (5.5 mmol/mol). We estimated the odds of people experiencing a rapid eGFR annual decline using a logistic regression and differences across HVS categories in the mean eGFR slope using a mixed-effect model. The analysis involved 2397 individuals and a median follow-up of 4.7 years. Compared with people with HVS ≤ 20%, those with HVS of 60% to 80% had 11% higher odds of experiencing rapid eGFR annual decline, with an extra eGFR decline of 0.93 mL/min/1.73 m2 per year on average; those with HVS > 80% showed 26% higher odds of experiencing a rapid eGFR annual decline, with an extra decline of 1.83 mL/min/1.73 m2 per year on average. Chinese adults with type 2 diabetes and HVS > 60% could experience a more rapid eGFR decline.